Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

August 8, 2022

Epigenic Therapeutics secures funds to advance gene editing therapy

Chinese biotechnology firm Epigenic Therapeutics has secured $20m in Series Angel and Pre-A funding to proceed with next-generation gene editing therapy.

Epigenic Therapeutics secures funds to advance gene editing therapy